Cresta Advisors, Ltd. Eli Lilly & CO Transaction History
Cresta Advisors, Ltd.
- $169 Million
- Q2 2024
A detailed history of Cresta Advisors, Ltd. transactions in Eli Lilly & CO stock. As of the latest transaction made, Cresta Advisors, Ltd. holds 535 shares of LLY stock, worth $453,054. This represents 0.29% of its overall portfolio holdings.
Number of Shares
535
Previous 511
4.7%
Holding current value
$453,054
Previous $397,000
21.91%
% of portfolio
0.29%
Previous 0.25%
Shares
3 transactions
Others Institutions Holding LLY
# of Institutions
3,905Shares Held
765MCall Options Held
6.35MPut Options Held
7.95M-
Lilly Endowment Inc Indianapolis, IN96.9MShares$82.1 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA73.9MShares$62.5 Billion1.31% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$55.8 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$43.5 Billion31.1% of portfolio
-
State Street Corp Boston, MA33.9MShares$28.7 Billion1.36% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $805B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...